-
When it comes to emergency contraception (EC), placement of a Copper T 380A intrauterine device [(IUD), ParaGard, Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals; Pomona, NY] offers excellent protection against unwanted pregnancy, as well as long-term contraception. What are some of the roadblocks that may hinder its use?
-
The Food and Drug Administration (FDA) has approved two new tests for human papillomavirus (HPV). How does the addition of these tests affect current practice?
-
During his 2008 campaign and in the budget framework that President Obama sent to Congress late in February, he signaled his support for a U-turn in federal policy to prevent pregnancy and sexually transmitted infections (STIs) among American youth.
-
Female-controlled prevention options are set to expand with the Food and Drug Administration (FDA) March 2009 approval of the second generation of the female condom manufactured by the Female Health Co.
-
If your practice includes care of pregnant women, be sure to review just-issued interim guidance from the Centers for Disease Control and Prevention (CDC) in regard to swine influenza A (H1N1) virus infection.
-
Women who have been searching for the Today contraceptive sponge on pharmacy shelves can stop hunting: Mayer Laboratories now serves as the U.S. distributor for the over-the-counter contraceptive.
-
The Food and Drug Administration (FDA) is complying with a federal judge's instruction and is directing the manufacturers of the dedicated emergency contraceptive pill Plan B to make the drug available to 17-year-olds without prescription.
-
How is your facility coping with the current economic downturn? Look to the July issue of Contraceptive Technology Update for special focus articles that will report on such up-to-the-moment items as these:
-
Findings from two parallel clinical trials in Rakai, Uganda, indicate that heterosexual men who undergo medical circumcision can significantly reduce their risk of acquiring two common sexually transmitted diseases (STDs): herpes simplex virus type 2 (HSV-2) and human papillomavirus (HPV).
-
Sexually transmitted diseases (STDs) remain a major U.S. public health challenge. About 19 million new infections occur each year, with almost half of them among young people ages 15 to 24.1 What are you doing to close the gaps when it comes to STD prevention in this age group?
